CUBIST PHARMACEUTICALS INC Operating Income
CUBIST PHARMACEUTICALS INC reported Operating Income of $67.81 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2014-11-07
- CUBIST PHARMACEUTICALS INC operating income (loss) for the quarter ending 2014-09-30 was $67.81M, a 1571.82% increase year-over-year.
- CUBIST PHARMACEUTICALS INC operating income (loss) for the quarter ending 2014-06-30 was $42.17M, a 50.22% increase year-over-year.
- CUBIST PHARMACEUTICALS INC operating income (loss) for the quarter ending 2014-03-31 was $28.31M, a 189.10% increase year-over-year.
- CUBIST PHARMACEUTICALS INC operating income (loss) for the quarter ending 2013-12-31 was -$15.51M, a 134.26% decline year-over-year.
- CUBIST PHARMACEUTICALS INC operating income (loss) for fiscal 2013 was $26.41M, a 88.86% decline from fiscal 2012.
- CUBIST PHARMACEUTICALS INC operating income (loss) for fiscal 2012 was $237.11M, a 78.91% increase from fiscal 2011.
- CUBIST PHARMACEUTICALS INC operating income (loss) for fiscal 2011 was $132.53M, a 30.10% decline from fiscal 2010.
- CUBIST PHARMACEUTICALS INC operating income (loss) for fiscal 2010 was $189.60M, a 37.63% increase from fiscal 2009.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2014-09-30 | $67.81M 10-Q · filed 2014-11-07 | $109.98M derived: sum of 2 quarters · filed 2014-11-07 | $138.29M 10-Q · filed 2014-11-07 | $122.78M derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-06-30 | $42.17M 10-Q · filed 2014-08-11 | $70.48M 10-Q · filed 2014-08-11 | $54.97M derived: sum of 3 quarters · filed 2014-08-11 | $59.02M derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-03-31 | $28.31M 10-Q · filed 2014-05-02 | $12.80M derived: sum of 2 quarters · filed 2014-05-02 | $16.85M derived: sum of 3 quarters · filed 2014-11-07 | $44.92M derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-12-31 | -$15.51M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$11.45M derived: sum of 2 quarters · filed 2014-11-07 | $16.62M derived: sum of 3 quarters · filed 2014-11-07 | $26.41M 10-K · filed 2014-02-25 |
| 2013-09-30 | $4.06M 10-Q · filed 2014-11-07 | $32.13M derived: sum of 2 quarters · filed 2014-11-07 | $41.92M 10-Q · filed 2014-11-07 | $87.19M derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | $28.07M 10-Q · filed 2014-08-11 | $37.86M 10-Q · filed 2014-08-11 | $83.14M derived: sum of 3 quarters · filed 2014-08-11 | $153.49M derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-03-31 | $9.79M 10-Q · filed 2014-05-02 | $55.07M derived: sum of 2 quarters · filed 2014-05-02 | $125.42M derived: sum of 3 quarters · filed 2014-05-02 | $186.94M derived: sum of 4 quarters · filed 2014-05-02 |
| 2012-12-31 | $45.27M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $115.63M derived: sum of 2 quarters · filed 2014-02-25 | $177.15M derived: sum of 3 quarters · filed 2014-02-25 | $237.11M 10-K · filed 2014-02-25 |
| 2012-09-30 | $70.35M 10-Q · filed 2013-11-12 | $131.87M derived: sum of 2 quarters · filed 2013-11-12 | $191.83M 10-Q · filed 2013-11-12 | $235.12M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $61.52M 10-Q · filed 2013-08-06 | $121.48M 10-Q · filed 2013-08-06 | $164.77M derived: sum of 3 quarters · filed 2014-02-25 | $233.90M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $59.96M 10-Q · filed 2013-05-07 | $103.25M derived: sum of 2 quarters · filed 2014-02-25 | $172.38M derived: sum of 3 quarters · filed 2014-02-25 | $148.21M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $43.29M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $112.42M derived: sum of 2 quarters · filed 2014-02-25 | $88.25M derived: sum of 3 quarters · filed 2014-02-25 | $132.53M 10-K · filed 2014-02-25 |
| 2011-09-30 | $69.13M 10-Q · filed 2012-11-05 | $44.96M derived: sum of 2 quarters · filed 2012-11-05 | $89.24M 10-Q · filed 2012-11-05 | $135.64M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | -$24.17M 10-Q · filed 2012-08-07 | $20.11M 10-Q · filed 2012-08-07 | $66.51M derived: sum of 3 quarters · filed 2013-02-27 | $118.64M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $44.28M 10-Q · filed 2012-05-01 | $90.68M derived: sum of 2 quarters · filed 2013-02-27 | $142.81M derived: sum of 3 quarters · filed 2013-02-27 | $196.54M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $46.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $98.53M derived: sum of 2 quarters · filed 2013-02-27 | $152.27M derived: sum of 3 quarters · filed 2013-02-27 | $189.60M 10-K · filed 2013-02-27 |
| 2010-09-30 | $52.13M 10-Q · filed 2011-11-02 | $105.87M derived: sum of 2 quarters · filed 2011-11-02 | $143.20M 10-Q · filed 2011-11-02 | $183.77M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $53.74M 10-Q · filed 2011-07-29 | $91.07M 10-Q · filed 2011-07-29 | $131.64M derived: sum of 3 quarters · filed 2012-02-27 | $177.14M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | $37.33M 10-Q · filed 2011-04-29 | $77.90M derived: sum of 2 quarters · filed 2012-02-27 | $123.40M derived: sum of 3 quarters · filed 2012-02-27 | $159.31M derived: sum of 4 quarters · filed 2012-02-27 |
| 2009-12-31 | $40.57M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $86.07M derived: sum of 2 quarters · filed 2012-02-27 | $121.97M derived: sum of 3 quarters · filed 2012-02-27 | $137.76M 10-K · filed 2012-02-27 |
| 2009-09-30 | $45.50M 10-Q · filed 2010-10-29 | $81.40M derived: sum of 2 quarters · filed 2010-10-29 | $97.19M 10-Q · filed 2010-10-29 | |
| 2009-06-30 | $35.91M 10-Q · filed 2010-07-30 | $51.69M 10-Q · filed 2010-07-30 | ||
| 2008-12-31 | $90.89M 10-K · filed 2011-02-23 |